ID

18782

Description

Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00228150

Link

https://clinicaltrials.gov/show/NCT00228150

Keywords

Versions (1)
  1. 11/20/16 11/20/16 -
Uploaded on

November 20, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Parkinson Disease NCT00228150

English

Eligibility Parkinson Disease NCT00228150

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female outpatients.
Description

Gender | Outpatients

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0029921
age >=35 years at screening.·
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of parkinson's syndrome, on at least two of the three key parkinson's symptoms, i.e. resting tremor, bradykinesia and rigidity.
Description

Parkinson Disease Symptoms Quantity | Resting Tremor | Bradykinesia | Rigidity

Data type

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C1457887
UMLS CUI [1,3]
C1265611
UMLS CUI [2]
C0234379
UMLS CUI [3]
C0233565
UMLS CUI [4]
C0026837
duration of the disease of less than 3 years since diagnosis·
Description

disease length

Data type

boolean

Alias
UMLS CUI [1]
C0872146
modified hoehn and yahr stage <= 2.5.
Description

UPDRS - Modified Hoehn and Yahr Staging

Data type

boolean

Alias
UMLS CUI [1]
C3639878
untreated patients.
Description

Patients untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
generally healthy and ambulatory.
Description

General health good | Ambulatory

Data type

boolean

Alias
UMLS CUI [1]
C1277245
UMLS CUI [2]
C0439841
patient has given his informed written consent and is capable of following study procedures.
Description

Informed Consent | Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any indication of forms of parkinsonism other than pd.
Description

Indication Parkinsonian Disorders | Parkinson Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0242422
UMLS CUI [2]
C0030567
severe resting tremor.
Description

Resting Tremor Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0234379
UMLS CUI [1,2]
C0205082
presence of either dyskinesia, fluctuations, or loss of postural reflexes·
Description

Dyskinetic syndrome | Motor fluctuations | Postural reflex Loss

Data type

boolean

Alias
UMLS CUI [1]
C0013384
UMLS CUI [2]
C1868976
UMLS CUI [3,1]
C0234154
UMLS CUI [3,2]
C1517945
treatment with l-dopa, dopamine agonist, amantadine, anticholinergics, catechol-o-methyltransferase (comt ) inhibitors, selegiline, dopamine receptor antagonists, catecholamine depleters, indirect dopamine agonists or alphamethyldopa.
Description

Levodopa | Dopamine Agonists | Amantadine | Anticholinergic Agents | Catechol-O-methyltransferase inhibitor | Selegiline | Dopamine Antagonists | catecholamine inhibitor | Dopamine Agonists Indirect | Methyldopa

Data type

boolean

Alias
UMLS CUI [1]
C0023570
UMLS CUI [2]
C0178601
UMLS CUI [3]
C0002403
UMLS CUI [4]
C0242896
UMLS CUI [5]
C0595267
UMLS CUI [6]
C0036579
UMLS CUI [7]
C0242702
UMLS CUI [8]
C0596280
UMLS CUI [9,1]
C0178601
UMLS CUI [9,2]
C0439852
UMLS CUI [10]
C0025741
electroconvulsive therapy (ect).
Description

Electroconvulsive Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0013806
use of cyp3a4 strong, and moderate inducers or inhibitors.
Description

CYP3A4 Inducers Strong | CYP3A4 Inducers Moderate | CYP3A4 Inhibitors Strong | CYP3A4 Inhibitors Moderate

Data type

boolean

Alias
UMLS CUI [1,1]
C3850041
UMLS CUI [1,2]
C0442821
UMLS CUI [2,1]
C3850041
UMLS CUI [2,2]
C0205081
UMLS CUI [3,1]
C3850053
UMLS CUI [3,2]
C0442821
UMLS CUI [4,1]
C3850053
UMLS CUI [4,2]
C0205081
participation in another clinical trial with an investigational drug within two months prior to randomization.
Description

Study Subject Participation Status | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
dementia, uncontrolled depression, psychotic disorder.
Description

Dementia | Depressive disorder Uncontrolled | Psychotic Disorder

Data type

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2,1]
C0011581
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0033975
history of substance-related disorders including alcohol or other substance use disorders.
Description

Substance Use Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0038586
females of child bearing potential.
Description

Childbearing Potential

Data type

boolean

Alias
UMLS CUI [1]
C3831118
evidence (detected by history, physical examination and/or laboratory/ecg tests) of any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug.
Description

Disease Clinical Significance Interferes with Study Subject Participation Status | Disease Unstable Interferes with Study Subject Participation Status | Medical History | Physical Examination | Laboratory Tests | ECG finding | Disease Unstable Interferes with Investigational New Drug absorption | Disease Unstable Interferes with Investigational New Drug metabolism | Disease Unstable Interferes with Investigational New Drug excretion | Disease Unstable Interferes with Investigational New Drug Evaluation

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0443343
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C2348568
UMLS CUI [3]
C0262926
UMLS CUI [4]
C0031809
UMLS CUI [5]
C0022885
UMLS CUI [6]
C0438154
UMLS CUI [7,1]
C0012634
UMLS CUI [7,2]
C0443343
UMLS CUI [7,3]
C0521102
UMLS CUI [7,4]
C0013230
UMLS CUI [7,5]
C0678745
UMLS CUI [8,1]
C0012634
UMLS CUI [8,2]
C0443343
UMLS CUI [8,3]
C0521102
UMLS CUI [8,4]
C0013230
UMLS CUI [8,5]
C0025520
UMLS CUI [9,1]
C0012634
UMLS CUI [9,2]
C0443343
UMLS CUI [9,3]
C0521102
UMLS CUI [9,4]
C0013230
UMLS CUI [9,5]
C0683141
UMLS CUI [10,1]
C0012634
UMLS CUI [10,2]
C0443343
UMLS CUI [10,3]
C0521102
UMLS CUI [10,4]
C0013230
UMLS CUI [10,5]
C1261322
alterations of laboratory tests or ecg findings of potential clinical significance.
Description

Laboratory Tests Alteration | ECG finding Clinical Significance potential

Data type

boolean

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C1515926
UMLS CUI [2,1]
C0438154
UMLS CUI [2,2]
C2826293
UMLS CUI [2,3]
C3245505
Back to the top of the page

Similar models

Eligibility Parkinson Disease NCT00228150

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Outpatients
Item
male or female outpatients.
boolean
C0079399 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
Age
Item
age >=35 years at screening.·
boolean
C0001779 (UMLS CUI [1])
Parkinson Disease Symptoms Quantity | Resting Tremor | Bradykinesia | Rigidity
Item
diagnosis of parkinson's syndrome, on at least two of the three key parkinson's symptoms, i.e. resting tremor, bradykinesia and rigidity.
boolean
C0030567 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0234379 (UMLS CUI [2])
C0233565 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
disease length
Item
duration of the disease of less than 3 years since diagnosis·
boolean
C0872146 (UMLS CUI [1])
UPDRS - Modified Hoehn and Yahr Staging
Item
modified hoehn and yahr stage <= 2.5.
boolean
C3639878 (UMLS CUI [1])
Patients untreated
Item
untreated patients.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
General health good | Ambulatory
Item
generally healthy and ambulatory.
boolean
C1277245 (UMLS CUI [1])
C0439841 (UMLS CUI [2])
Informed Consent | Protocol Compliance
Item
patient has given his informed written consent and is capable of following study procedures.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Indication Parkinsonian Disorders | Parkinson Disease
Item
any indication of forms of parkinsonism other than pd.
boolean
C3146298 (UMLS CUI [1,1])
C0242422 (UMLS CUI [1,2])
C0030567 (UMLS CUI [2])
Resting Tremor Severe
Item
severe resting tremor.
boolean
C0234379 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Dyskinetic syndrome | Motor fluctuations | Postural reflex Loss
Item
presence of either dyskinesia, fluctuations, or loss of postural reflexes·
boolean
C0013384 (UMLS CUI [1])
C1868976 (UMLS CUI [2])
C0234154 (UMLS CUI [3,1])
C1517945 (UMLS CUI [3,2])
Levodopa | Dopamine Agonists | Amantadine | Anticholinergic Agents | Catechol-O-methyltransferase inhibitor | Selegiline | Dopamine Antagonists | catecholamine inhibitor | Dopamine Agonists Indirect | Methyldopa
Item
treatment with l-dopa, dopamine agonist, amantadine, anticholinergics, catechol-o-methyltransferase (comt ) inhibitors, selegiline, dopamine receptor antagonists, catecholamine depleters, indirect dopamine agonists or alphamethyldopa.
boolean
C0023570 (UMLS CUI [1])
C0178601 (UMLS CUI [2])
C0002403 (UMLS CUI [3])
C0242896 (UMLS CUI [4])
C0595267 (UMLS CUI [5])
C0036579 (UMLS CUI [6])
C0242702 (UMLS CUI [7])
C0596280 (UMLS CUI [8])
C0178601 (UMLS CUI [9,1])
C0439852 (UMLS CUI [9,2])
C0025741 (UMLS CUI [10])
Electroconvulsive Therapy
Item
electroconvulsive therapy (ect).
boolean
C0013806 (UMLS CUI [1])
CYP3A4 Inducers Strong | CYP3A4 Inducers Moderate | CYP3A4 Inhibitors Strong | CYP3A4 Inhibitors Moderate
Item
use of cyp3a4 strong, and moderate inducers or inhibitors.
boolean
C3850041 (UMLS CUI [1,1])
C0442821 (UMLS CUI [1,2])
C3850041 (UMLS CUI [2,1])
C0205081 (UMLS CUI [2,2])
C3850053 (UMLS CUI [3,1])
C0442821 (UMLS CUI [3,2])
C3850053 (UMLS CUI [4,1])
C0205081 (UMLS CUI [4,2])
Study Subject Participation Status | Investigational New Drugs
Item
participation in another clinical trial with an investigational drug within two months prior to randomization.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Dementia | Depressive disorder Uncontrolled | Psychotic Disorder
Item
dementia, uncontrolled depression, psychotic disorder.
boolean
C0497327 (UMLS CUI [1])
C0011581 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0033975 (UMLS CUI [3])
Substance Use Disorders
Item
history of substance-related disorders including alcohol or other substance use disorders.
boolean
C0038586 (UMLS CUI [1])
Childbearing Potential
Item
females of child bearing potential.
boolean
C3831118 (UMLS CUI [1])
Disease Clinical Significance Interferes with Study Subject Participation Status | Disease Unstable Interferes with Study Subject Participation Status | Medical History | Physical Examination | Laboratory Tests | ECG finding | Disease Unstable Interferes with Investigational New Drug absorption | Disease Unstable Interferes with Investigational New Drug metabolism | Disease Unstable Interferes with Investigational New Drug excretion | Disease Unstable Interferes with Investigational New Drug Evaluation
Item
evidence (detected by history, physical examination and/or laboratory/ecg tests) of any clinically significant or unstable medical disorder that could interfere with the patient's participation in the clinical trial; interfere with the absorption, metabolism or excretion of the study medication; or interfere with the evaluation of the study drug.
boolean
C0012634 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C2348568 (UMLS CUI [2,4])
C0262926 (UMLS CUI [3])
C0031809 (UMLS CUI [4])
C0022885 (UMLS CUI [5])
C0438154 (UMLS CUI [6])
C0012634 (UMLS CUI [7,1])
C0443343 (UMLS CUI [7,2])
C0521102 (UMLS CUI [7,3])
C0013230 (UMLS CUI [7,4])
C0678745 (UMLS CUI [7,5])
C0012634 (UMLS CUI [8,1])
C0443343 (UMLS CUI [8,2])
C0521102 (UMLS CUI [8,3])
C0013230 (UMLS CUI [8,4])
C0025520 (UMLS CUI [8,5])
C0012634 (UMLS CUI [9,1])
C0443343 (UMLS CUI [9,2])
C0521102 (UMLS CUI [9,3])
C0013230 (UMLS CUI [9,4])
C0683141 (UMLS CUI [9,5])
C0012634 (UMLS CUI [10,1])
C0443343 (UMLS CUI [10,2])
C0521102 (UMLS CUI [10,3])
C0013230 (UMLS CUI [10,4])
C1261322 (UMLS CUI [10,5])
Laboratory Tests Alteration | ECG finding Clinical Significance potential
Item
alterations of laboratory tests or ecg findings of potential clinical significance.
boolean
C0022885 (UMLS CUI [1,1])
C1515926 (UMLS CUI [1,2])
C0438154 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
C3245505 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial